CSIMarket
 


Co diagnostics Inc   (CODX)
Other Ticker:  
 
 

CODX's Revenue Growth by Quarter and Year

Co Diagnostics Inc 's Revenue results by quarter and year




CODX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 3.37 1.40 20.40 27.15
III Quarter September 2.46 5.09 30.10 21.82
II Quarter June 0.20 5.02 27.36 24.04
I Quarter March 0.60 22.70 20.02 1.55
FY   6.63 34.21 97.88 74.56



CODX Revenue fourth quarter 2023 Y/Y Growth Comment
Co diagnostics Inc reported Revenue surge of 140.73% year on year in the fourth quarter 2023, to $ 3.37 millions, this is lower than Co Diagnostics Inc 's recent average Revenue surge of 6807.58%.

Looking into fourth quarter 2023 results within Medical Equipment & Supplies industry 93 other companies have achieved higher Revenue growth. While Co Diagnostics Inc ' s Revenue doubling of 140.73% ranks overall at the positon no. 2294 in the fourth quarter 2023.




CODX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December 140.73 % -93.14 % -24.86 % 24581.82 %
III Quarter September -51.67 % -83.09 % 37.95 % 54450 %
II Quarter June -96.02 % -81.65 % 13.81 % 39966.67 %
I Quarter March -97.36 % 13.39 % 1191.61 % -
FY   -80.62 % -65.05 % 31.28 % 35404.76 %

Financial Statements
Co Diagnostics Inc 's fourth quarter 2023 Revenue $ 3.37 millions CODX's Income Statement
Co Diagnostics Inc 's fourth quarter 2022 Revenue $ 1.40 millions Quarterly CODX's Income Statement
New: More CODX's historic Revenue Growth >>


CODX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 37 % -72.5 % -32.23 % 24.43 %
III Quarter September 1130 % 1.39 % 10.01 % -9.23 %
II Quarter June -66.67 % -77.89 % 36.66 % 1450.97 %
I Quarter March -57.14 % 11.27 % -26.26 % 1309.09 %
FY (Year on Year)   -80.62 % -65.05 % 31.28 % 35404.76 %




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #279
Overall #2294

Revenue Y/Y Growth Statistics
High Average Low
40432.04 % 6807.58 % -91.25 %
(Sep 30 2020)   (Sep 30 2023)
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #94
Healthcare Sector #279
Overall #2294
Revenue Y/Y Growth Statistics
High Average Low
40432.04 % 6807.58 % -91.25 %
(Sep 30 2020)   (Sep 30 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Co Diagnostics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1711 % 238.39 % -77.87 %
(Jun 30 2019)  


CODX's IV. Quarter Q/Q Revenue Comment
Co diagnostics Inc achieved in the IV. Quarter 2023 below company average Revenue jump of 37% quarter on quarter, to $ 3.37 millions.

IV. Quarter 2023 Co Diagnostics Inc 's performance seem to be contradictory, although beneath the average increase of 238.39 %, yet it presents real recovery measured to the -72.5% in the same quarter a year ago

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Co Diagnostics Inc 's Revenue growth quarter on quarter, overall rank is 203.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #41
Overall #203
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #5
Healthcare Sector #41
Overall #203
Revenue Q/Q Growth Statistics
High Average Low
1711 % 238.39 % -77.87 %
(Jun 30 2019)  


CODX's IV. Quarter Q/Q Revenue Comment
Co diagnostics Inc achieved in the IV. Quarter 2023 below company average Revenue jump of 37% quarter on quarter, to $ 3.37 millions.

Even if the IV. Quarter 2023 Revenue sequential growth was beneath the regular , it has been yet promising news, as the IV. Quarter improvement, transcends the -72.5% rise in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Co Diagnostics Inc 's Revenue growth quarter on quarter, overall rank is 203.


Co Diagnostics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 6.63 $ 4.66 $ 7.30 $ 12.12 $ 34.22
Y / Y Revenue Growth (TTM) -80.63 % -91.25 % -90.67 % -87.95 % -65.04 %
Year on Year Revenue Growth Overall Ranking # 2365 # 3170 # 2906 # 1614 # 86
Seqeuential Revenue Change (TTM) 42.26 % -36.15 % -39.81 % -64.58 % -35.7 %
Seq. Revenue Growth (TTM) Overall Ranking # 2294 # 3030 # 3365 # 1994 # 1362




Cumulative Revenue growth Comment
Co Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Co Diagnostics Inc 's annual Revenue drop would be -80.63% year on year to $7 millions.

In the Healthcare sector 289 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2365, from total ranking in previous quarter at 3170.

Revenue TTM Q/Q Growth Statistics
High Average Low
40432.04 %
6807.58 %
-91.25 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 290
Overall # 2365

Revenue TTM Y/Y Growth Statistics
High Average Low
40432.04 %
6807.58 %
-91.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 279
S&P 500 # 2294
Cumulative Revenue growth Comment
Co Diagnostics Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2023. If the fiscal year would end in Dec 31 2023, Co Diagnostics Inc 's annual Revenue drop would be -80.63% year on year to $7 millions.

In the Healthcare sector 289 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2365, from total ranking in previous quarter at 3170.

Revenue TTM Q/Q Growth Statistics
High Average Low
40432.04 %
6807.58 %
-91.25 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 94
Healthcare Sector # 290
Overall # 2365

Revenue TTM Y/Y Growth Statistics
High Average Low
40432.04 %
6807.58 %
-91.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 94
Sector # 279
S&P 500 # 2294




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CODX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for CODX's Competitors
Revenue Growth for Co Diagnostics Inc 's Suppliers
Revenue Growth for CODX's Customers

You may also want to know
CODX's Annual Growth Rates CODX's Profitability Ratios CODX's Asset Turnover Ratio CODX's Dividend Growth
CODX's Roe CODX's Valuation Ratios CODX's Financial Strength Ratios CODX's Dividend Payout Ratio
CODX's Roa CODX's Inventory Turnover Ratio CODX's Growth Rates CODX's Dividend Comparisons



Companies with similar Revenue drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Ovid Therapeutics Inc 205.88%$ 205.884 millions
Lipocine Inc 164.58%$ 164.577 millions
Blueprint Medicines Corporation163.28%$ 163.282 millions
Celldex Therapeutics inc 156.11%$ 156.107 millions
Co diagnostics Inc 140.48%$ 140.476 millions
Aclaris Therapeutics Inc 126.62%$ 126.622 millions
Globus Medical Inc 124.60%$ 124.604 millions
Roivant Sciences Ltd 117.80%$ 117.804 millions
Intelligent Bio Solutions Inc 114.22%$ 114.216 millions
Pacific Biosciences Of California Inc 113.62%$ 113.622 millions
Docgo Inc 112.37%$ 112.366 millions
Ionis Pharmaceuticals Inc112.32%$ 112.319 millions
Encompass Health Corporation109.55%$ 109.546 millions
Xencor Inc106.80%$ 106.798 millions
Coherus Biosciences inc 101.81%$ 101.808 millions
Palatin Technologies Inc 98.18%$ 98.176 millions
Hutchmed china Limited96.52%$ 96.525 millions
Alimera Sciences Inc 89.98%$ 89.978 millions
Procept Biorobotics Corporation83.65%$ 83.652 millions
Ptc Therapeutics inc 83.41%$ 83.412 millions
Catalyst Pharmaceuticals Inc 81.98%$ 81.984 millions
Enovis Corporation79.22%$ 79.224 millions
Esperion Therapeutics inc 71.38%$ 71.378 millions
Electrocore Inc 71.37%$ 71.367 millions
Cvrx inc70.81%$ 70.805 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com